Full Press Release Details
| Dr. Reddy's Laboratories Ltd. | |
| 8-2-337, Road No. 3, Banjara Hills, | |
| Hyderabad - 500 034, Telangana, | |
| India. | |
| CIN : L85195TG1984PLC004507 |
| Tel | :+91 40 4900 2900 | |
| Fax | :+91 40 4900 2999 | |
| :mail@drreddys.com | ||
| www.drreddys.com |
| Corporate Relationship Department | National Stock Exchange of India Ltd. |
| BSE Limited | "Exchange Plaza" |
| Dalal Street, Fort | Bandra-Kurla Complex, Bandra (East), |
| Mumbai - 400 001 | Mumbai - 400 051 |
| Fax Nos.: 022-22723121 / 22723719 / | Fax Nos.: 022-26598120/ 26598237/ |
| 22722037 / 22722039 | 26598238 |
| Scrip Code: 500124 | Scrip Code: DRREDDY-EQ |
Further to our intimation dated October
26, 2019 with regard to the audit of our API Srikakulam Plant (SEZ), Andhra Pradesh, we would like to inform you that we have received
the Establishment Inspection Report (EIR) from US FDA, for the above-referred facility, indicating that the inspection is "closed"
under 21 CFR 20.64(d)(3).
This is for your information.
| /s/ Sandeep Poddar | |
| Sandeep Poddar | |
| Company Secretary |
CC:- New York Stock Exchange Inc.(Stock Code :RDY)